NEW YORK (GenomeWeb News) – Oxford Gene Technology has licensed the rights to make and market certain oligonucleotide microarrays using the company’s Southern array patents to BF-BIOlabs, OGT said today.
Under the license, BF-BIOlabs will be able to sell arrays and array-based services for identifying genes, SNPs, and gene expression analysis.
OGT said the license will remain valid for the lifetime of the patents. Financial terms of the agreement were not released.
BF-BIOlabs offers services for microarray experiments, chip readout, and data analysis. In addition to patent licensing, OGT also focuses on digital microarrays, single cell analysis, cytogenetetics products, and high-throughput microarray services.